C3 and lung cancer: To identify the biological role of C3 in lung cancer resistance to PTX, we knocked down C3 expression in A549-PTX cells (Fig. S1B) and found that the viability and colony formation capability of the C3-insufficient cells were dramatically decreased after PTX treatment (Fig. 2A, B and C).